Impact of Serial B-Type Natriuretic Peptide Changes for Predicting Outcome in Asymptomatic Patients With Aortic Stenosis.

[1]  G. Maurer,et al.  The role of biomarkers in valvular heart disease: focus on natriuretic peptides. , 2014, The Canadian journal of cardiology.

[2]  C. Oury,et al.  Usefulness of serial B-type natriuretic peptide assessment in asymptomatic aortic stenosis. , 2014, The American journal of cardiology.

[3]  Nancy M Albert,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, The Journal of thoracic and cardiovascular surgery.

[4]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[5]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[6]  A. Jaffe,et al.  B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. , 2014, Journal of the American College of Cardiology.

[7]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[8]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[9]  B. Carabello.  Should severe aortic stenosis be operated on before symptom onset? Aortic valve replacement should be operated on before symptom onset. , 2012, Circulation.

[10]  P. Shah.  Severe Aortic Stenosis Should Not Be Operated on Before Symptom Onset , 2012, Circulation.

[11]  H. Baumgartner,et al.  Prognostic value of serial B‐type natriuretic peptide measurement in asymptomatic organic mitral regurgitation , 2011, European journal of heart failure.

[12]  P. Oberti,et al.  Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation. , 2009, Journal of the American College of Cardiology.

[13]  I. Riečanský,et al.  [Natriuretic peptides in patients with aortic stenosis]. , 2010, Vnitrni lekarstvi.

[14]  J. Daubert,et al.  Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay , 2010, Heart.

[15]  E. Donal,et al.  Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis. , 2010, The American journal of cardiology.

[16]  J. Chambers,et al.  Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  C. Hassager,et al.  Left atrial volume in patients with asymptomatic aortic valve stenosis (the Simvastatin and Ezetimibe in Aortic Stenosis study). , 2008, The American journal of cardiology.

[18]  Helmut Baumgartner,et al.  Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .

[19]  J. Sharman,et al.  Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. , 2006, Journal of the American College of Cardiology.

[20]  H. Rimington,et al.  Exercise testing to stratify risk in aortic stenosis. , 2005, European heart journal.

[21]  A. Richards,et al.  Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. , 2005, The American journal of cardiology.

[22]  J. Garot,et al.  Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. , 2004, European heart journal.

[23]  J. Bartunek,et al.  Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[24]  H. Baumgartner,et al.  Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis , 2004, Circulation.

[25]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[26]  Douglas W Mahoney,et al.  Plasma brain natriuretic peptide concentration: impact of age and gender. , 2002, Journal of the American College of Cardiology.

[27]  K. E. Werner,et al.  Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing , 2001, Heart.

[28]  G. Porenta,et al.  Predictors of outcome in severe, asymptomatic aortic stenosis , 2001 .